PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY END-USER • Market segmentation by end-user • Comparison by end-user • Biopharmaceutical companies - Market size and forecast 2018-2023 • Research institutes - Market size and forecast 2018-2023 • Contract research organizations - Market size and forecast 2018-2023 • Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 10: MARKET TRENDS PART 11: VENDOR LANDSCAPE • Overview • Landscape disruption PART 12: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Danaher • GE Healthcare • Merck KGaA • Sartorius • Thermo Fisher Scientific PART 13: APPENDIX Exhibit 01: Global biotechnology market Exhibit 02: Segments of global biotechnology market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: End-user - Market share 2018-2023 (%) Exhibit 18: Comparison by end-user Exhibit 19: Biopharmaceutical companies - Market size and forecast 2018-2023 ($ millions) Exhibit 20: Biopharmaceutical companies - Year-over-year growth 2019-2023 (%) Exhibit 21: Research institutes - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Research institutes - Year-over-year growth 2019-2023 (%) Exhibit 23: Contract research organizations - Market size and forecast 2018-2023 ($ millions) Exhibit 24: Contract research organizations - Year-over-year growth 2019-2023 (%) Exhibit 25: Market opportunity by end-user Exhibit 26: Customer landscape Exhibit 27: Market share by geography 2018-2023 (%) Exhibit 28: Geographic comparison Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 30: North America - Year-over-year growth 2019-2023 (%) Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Europe - Year-over-year growth 2019-2023 (%) Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 34: Asia - Year-over-year growth 2019-2023 (%) Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 36: ROW - Year-over-year growth 2019-2023 (%) Exhibit 37: Key leading countries Exhibit 38: Market opportunity Exhibit 39: Impact of drivers and challenges Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Danaher - Vendor overview Exhibit 46: Danaher - Business segments Exhibit 47: Danaher - Organizational developments Exhibit 48: Danaher - Geographic focus Exhibit 49: Danaher - Segment focus Exhibit 50: Danaher - Key offerings Exhibit 51: GE Healthcare - Vendor overview Exhibit 52: GE Healthcare - Business segments Exhibit 53: GE Healthcare - Organizational developments Exhibit 54: GE Healthcare - Geographic focus Exhibit 55: GE Healthcare - Segment focus Exhibit 56: GE Healthcare - Key offerings Exhibit 57: Merck KGaA - Vendor overview Exhibit 58: Merck KGaA - Business segments Exhibit 59: Merck KGaA - Organizational developments Exhibit 60: Merck KGaA - Geographic focus Exhibit 61: Merck KGaA - Segment focus Exhibit 62: Merck KGaA - Key offerings Exhibit 63: Sartorius - Vendor overview Exhibit 64: Sartorius - Business segments Exhibit 65: Sartorius - Organizational developments Exhibit 66: Sartorius - Geographic focus Exhibit 67: Sartorius - Segment focus Exhibit 68: Sartorius - Key offerings Exhibit 69: Thermo Fisher Scientific - Vendor overview Exhibit 70: Thermo Fisher Scientific - Business segments Exhibit 71: Thermo Fisher Scientific - Organizational developments Exhibit 72: Thermo Fisher Scientific - Geographic focus Exhibit 73: Thermo Fisher Scientific - Segment focus Exhibit 74: Thermo Fisher Scientific - Key offerings    

Danaher GE Healthcare Merck KGaA Sartorius Thermo Fisher Scientific